A Day Up For Avenue Therapeutics, Inc.

Fri, Sep 30, 2022 at 07:42 PM
A Day Up For Avenue Therapeutics, Inc.

Avenue Therapeutics, Inc. (ATXI:NASDAQ) soared at $10.08, a gain of 39%. On Fri, Sep 30, 2022, ATXI:NASDAQ hit a New 2-Week High of $10.08. The stock got featured on our News Catalysts scanner on Fri, Sep 23, 2022 at 12:13 PM in the 'SPLIT' category. From Fri, Sep 16, 2022, the stock recorded 50.00% Up Days and 45.45% Green Days

About Avenue Therapeutics, Inc. (ATXI:NASDAQ)

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.